Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
The MM are up to the saem tricks.
a girlfriend bought 25k this am @ 46.57p . that is showing on the OTC info as a sell
From 3 new large medical customers Two of these customers operate in
the diagnostic field and the other in pharmaceuticals.
Annual report, say no more!!
Nice try MM 100k delayed trade from Friday, certainly got a few AUTO sells. What will they try next??
Thanks for posting Steelwatch.
Fenics,
If something had changed, anything, including the framework agreement, that could infulence the shareprice either in an upward or downward manner the company would be duty bound to issue inform shareholders, so as to avoid a false market.
I have pontificated over the past days as to what was happening and without further evidence I have to agree with others, a substantial shareholder has offloaded quite a few shares over the past week and that has convinced others to sell also.
Lets hope this is now at an end and we can resume normal business, mind you , investor confidence has been tested no doubt. JMO
Morning Beza,
Its a set back no doubt. I still feel its the heard instinct but stand to be corrected on that.
If this is 3% holder we should have been informaed by now and if its not a 3% holder they shouldnt have any shares left.
Our directors buying gives me confidence.
Hi Beza,
Another lovely day, and great golf!
For what it’s worth, the information I use for my analysis is no different to your own just that I look at total trades not buys or sells
Certainly there are sellers out there but I don’t see a concerted attempt by one or two large holders.
Results and presentation week 3.376million shares were traded (ftse) the price dipped 2p. Early buying then selling after the results/presentation, no information forthcoming re, the framework contracts.
The following week 1.721million shares traded (ftse), the price dipped 7p. Last week 2.687million traded (ftse) and a similar dip. I stated my opinion on this in my previous message.
Two weeks before the results 1.584million shares were traded when the price dipped 6p, June progressing, no info re when to expect results.
Finally in the week prior to results 976,171 shares traded (ftse) the share rose 5p in anticipation.
As I say, fwiw. My thoughts only.
Hi Mesquida,
What a great day today has been!
Looking at the volumes over the past few weeks nothing really stands out. I doubt myself if any 3% plus holder is reducing, if they wanted out they would have gone some time ago. No doubt I stand to be corrected (RNS Monday ;-).
I recon its folks seeing profits drift lower and are worrying, plus a few who bought at the recent highs. Clearly the more that are sold the more the fear grows and so on. You could almost see the exasperation in the 15.26.33 trade. 50,023 shares offered, bid 40.50p offer 41.60p. executed at 39.81p.
There is no doubt some are concerned ref, the framework agreement and orders yet to come. they will come, no company spends a few million on tooling, just to walk away.
I’ve listened again to the company presentation, they are making great progress, the business saw a 17% uplift in the second half. We are now in a completely new yea, lots of the problems and issues from LED days have gone. Both our Executive Chair and Finance Director talk about good progress.
The next figures will be all their own. I’m looking out for one or two positive surprises on the way.
JMO
Sorry.
Looks like the information is from 2018.
States clearly, was updated 3 days ago. ??
Says updated 3 days ago.
https://www.marketscreener.com/quote/stock/CARCLO-PLC-4001758/company/
Link safe.
There is an example for all Beza. I sold my entire holdings in Vectura just before the 1st bid.
I can also remember when BAT Industries (British American Tobacco) bought a life insurance company....sold it some years later after lots of flack.
Hi Beza,
I recall from the presentation that sales in h2 2021 were 57million and on a rising trend with new customers on board and tooling ready to go. Maybe a more accurate estimate of the t/o would be to get rid on 2022 forecast and replace with 2023. I won't speculate on the profit figures except to say costs have been taken out and exceptionals are on a downward trend. For 2023 remember "We need more space in Europe and Amarica" further we are working with existing customers at their overseas sites.....,,,,PH will upgrade as time passes... please except typos on a train, all my opinion only.
I added 25k @ 09.56am.
it was reported as an OTC (over the counter) trade and as a sell. It was neither.
Gutted, listening g in my car and lost signal after about 10mins. Wanted to ask a couple of questions...
Must say though was encouraged with bit I did hear.
Will listen tomorrow now.
I gave Phil White a new job.
That should read CFO
Welcome to the shareholders list Phil White our CEO.
And a third vote of confidence from our Executive Chairman.
Someone said underwhelming.....
I honestly can't see what's underwhelming.
Debt reduced
Retirement liabilities reduced.
Net cash generated up.
Finished the year on an improving trend.
Management simplified and strengthened.
Encouraged by 1st quarter. With good progress expected current year.
Managed pandemic.
Looking after employees.
3 New large medical customers .
Increased demand from existing customers.
Going after new business
Please tell me what is underwhelming in That???
Jmo
I
Oggy, if we knew the answer to your question we would be well on the way to being very rich indeed.
Take time and read some older posts, some posters/shareholders have taken an educated guess at the potential for the shares.
A lot now depends on the premlims due Wednesday and the companies review of the 1st quarter.
Also read company postings and updates. You might then get a better understanding of the companies worth and what it's shares price should or could be. Jmo. Good look whatever you decide.
Peel Hunt I believe.
The statement below, from our recent trading update doesn't hint at any cash raise in my opinion.
"A strong focus on cash generation has enabled the division to make significant investments in capital expenditure to support its ability to deliver on anticipated future production contracts without increasing net debt".